Bill Heiden | President, Chief Executive Officer |
Nik Grund | Chief Commercial Officer |
Ted Myles | Chief Financial Officer |
Linda Lennox | Vice President, Investor Relations |
Serge Belanger | Needham |
Thomas Smith | Morgan Stanley |
Bill Tanner | Cantor Fitzgerald |
Tyler Van Buren | Cowen & Co |
Eun Yang | Jefferies |
Morgan Williams | Barclays |
Chris Raymond | Piper Jaffray |
Joseph Schwartz | Leerink Partners |
Good morning. My name is Amy and I will be your conference operator today. At this time I would like to welcome everyone to the AMAG Pharmaceuticals' Third Quarter 2017 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.